SCHEMBL468893

SCHEMBL468893

CC(=O)N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 12/20 0.69
THRA P10827 8/20 0.69
MEN1 O00255 6/20 0.69
KMT2A Q03164 6/20 0.69
PPARG P37231 6/20 0.69
LMNA P02545 5/20 0.69
TTR P02766 2/20 0.69
ADORA3 P0DMS8 2/20 0.69
PDE4D Q08499 2/20 0.69
HSD17B10 Q99714 2/20 0.69
RXRA P19793 2/20 0.69
NR1I2 O75469 2/20 0.69
USP2 O75604 2/20 0.69
ALDH1A1 P00352 2/20 0.69
MAPT P10636 2/20 0.69
NR3C1 P04150 1/20 0.69
CYP1A2 P05177 1/20 0.69
HTR1A P08908 1/20 0.69
CYP2C9 P11712 1/20 0.69
TBXA2R P21731 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL468892 1.00 THRB (0.69) THRBTHRAMEN1KMT2APPARG
SCHEMBL31409224 0.92 THRB (0.65) THRBTHRAMEN1KMT2APPARG
SCHEMBL12844205 0.91 THRB (0.67) THRBTHRAMEN1KMT2APPARG
SCHEMBL1526146 0.90 THRB (0.56) THRBTHRAMEN1KMT2APPARG
SCHEMBL28626300 0.90 THRB (0.65) THRBTHRAMEN1KMT2APPARG
SCHEMBL13949745 0.89 THRB (0.64) THRBTHRAMEN1KMT2APPARG
SCHEMBL11190025 0.89 THRB (0.64) THRBTHRAMEN1KMT2APPARG
SCHEMBL10878152 0.89 THRB (0.60) THRBTHRAMEN1KMT2APPARG
SCHEMBL11190023 0.89 THRB (0.64) THRBTHRAMEN1KMT2APPARG
SCHEMBL468740 0.88 THRB (0.69) THRBTHRAMEN1KMT2APPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3039068-B1 MOISTURE CURABLE COMPOUND WITH AMINO ACIDS MOMENTIVE PERFORMANCE MAT INC (US) 2020-12-16 EP claimed
US-9914809-B2 Moisture curable composition with amino acids MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2018-03-13 US claimed
US-20160200880-A1 MOISTURE CURABLE COMPOSITION WITH AMINO ACIDS MOMENTIVE PERFORMANCE MATERIALS INC. 2016-07-14 US claimed
EP-3039068-A1 MOISTURE CURABLE COMPOUND WITH AMINO ACIDS Momentive Performance Materials Inc. (US) 2016-07-06 EP claimed
WO-2015031712-A1 MOISTURE CURABLE COMPOUND WITH AMINO ACIDS MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2015-03-05 WO claimed
US-RE44302-E1 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use YU RUEY J (US) 2013-06-18 US claimed
US-RE44017-E1 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use YU RUEY J (US) 2013-02-19 US claimed
US-RE42902-E1 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use TRISTRATA, INC. (US) 2011-11-08 US claimed
US-RE41339-E1 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use TRISTRATA, INC. (US) 2010-05-18 US claimed
US-RE41278-E1 N-acetyl aldosamines and related N-acetyl compounds, and their topical use TRISTRATA, INC. 2010-04-27 US claimed
EP-2080504-A2 Topical composition comprising n-acetylaldosamines or n-acetylamino acids Yu, Ruey J. (US) 2009-07-22 EP claimed
EP-1639994-A2 Topical composition comprising N-acetylaldosamines or N-acetylamino acids Yu, Ruey J., Dr. (US) 2006-03-29 EP claimed
EP-1570840-A2 TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS Yu, Ruey J., Dr. (US) 2005-09-07 EP claimed
US-6524593-B1 Alleviate or improve various cosmetic conditions and dermatological disorders, skin, hair, nails TRISTRATA, INC. 2003-02-25 US claimed
US-6159485-A COSMETICS; SKIN DISORDERS YUGENIC LIMITED PARTNERSHIP (US) 2000-12-12 US claimed
WO-2000040217-B1 TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS YUGENIC LIMITED PARTNERSHIP (US) 2000-10-05 WO claimed
EP-0649533-A4 REAGENTS AND METHODS FOR THE DETECTION AND QUANTIFICATION OF THYROXINE IN FLUID SAMPLES. ABBOTT LAB (US) 1996-08-21 EP claimed
EP-0649533-A1 REAGENTS AND METHODS FOR THE DETECTION AND QUANTIFICATION OF THYROXINE IN FLUID SAMPLES ABBOTT LABORATORIES (US) 1995-04-26 EP claimed
WO-1993020442-A1 REAGENTS AND METHODS FOR THE DETECTION AND QUANTIFICATION OF THYROXINE IN FLUID SAMPLES ABBOTT LABORATORIES (US) 1993-10-14 WO claimed
US-20260115330-A1 RADIOPAQUE MULTI-ARM POLYMERS FOR MEDICAL APPLICATIONS BOSTON SCIENTIFIC SCIMED, INC. (US) 2026-04-30 US disclosed
US-20260049178-A1 CROSSLINKING AGENTS AND MEDICAL HYDROGELS FORMED THEREFROM BOSTON SCIENTIFIC SCIMED, INC. (US) 2026-02-19 US disclosed
US-20260041799-A1 HYDROLYSIS-RESISTANT HYDROGELS AND METHODS OF TREATMENT USING SAME BOSTON SCIENTIFIC SCIMED, INC. (US) 2026-02-12 US disclosed
US-20260014282-A1 METHODS OF FORMING RADIOPAQUE PEPTIDES FOR USE IN MEDICAL HYDROGELS BOSTON SCIENTIFIC SCIMED, INC. (US) 2026-01-15 US disclosed
US-20250249130-A1 RADIOPAQUE POLYPEPTIDES FOR INJECTABLE COMPOSITIONS BOSTON SCIENTIFIC SCIMED, INC. (US) 2025-08-07 US disclosed
US-20250059237-A1 METHODS OF FORMING RADIOPAQUE PEPTIDES AND MEDICAL HYDROGELS FORMED THEREFROM BOSTON SCIENTIFIC SCIMED, INC. (US) 2025-02-20 US disclosed
WO-2025038709-A1 METHODS OF FORMING RADIOPAQUE PEPTIDES AND MEDICAL HYDROGELS FORMED THEREFROM BOSTON SCIENTIFIC SCIMED, INC. (US) 2025-02-20 WO disclosed
US-20250049964-A1 INJECTABLE SHEAR-THINNING AND SELF-ASSEMBLING HYDROGELS BOSTON SCIENTIFIC SCIMED, INC. (US) 2025-02-13 US disclosed
US-20240216539-A1 VECTOR FOR DELIVERING ACTIVE AGENT TO NERVOUS SYSTEM, AND USE THEREOF INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) 2024-07-04 US disclosed
US-20240216539-A1 VECTOR FOR DELIVERING ACTIVE AGENT TO NERVOUS SYSTEM, AND USE THEREOF INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) 2024-07-04 US disclosed
US-20240216539-A1 VECTOR FOR DELIVERING ACTIVE AGENT TO NERVOUS SYSTEM, AND USE THEREOF INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) 2024-07-04 US disclosed
WO-2023033202-A1 VECTOR FOR TRANSFERRING ACTIVE MATERIAL INTO NERVOUS SYSTEM, AND USE THEREOF 주식회사 툴젠 2023-03-09 WO disclosed
EP-2311452-B2 Topical composition comprising n-acetyl glucosamine YU RUEY J (US) 2020-12-30 EP disclosed
EP-3039068-B1 MOISTURE CURABLE COMPOUND WITH AMINO ACIDS MOMENTIVE PERFORMANCE MAT INC (US) 2020-12-16 EP disclosed
US-9914809-B2 Moisture curable composition with amino acids MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2018-03-13 US disclosed
US-20160200880-A1 MOISTURE CURABLE COMPOSITION WITH AMINO ACIDS MOMENTIVE PERFORMANCE MATERIALS INC. 2016-07-14 US disclosed
EP-3039068-A1 MOISTURE CURABLE COMPOUND WITH AMINO ACIDS Momentive Performance Materials Inc. (US) 2016-07-06 EP disclosed
WO-2015031712-A1 MOISTURE CURABLE COMPOUND WITH AMINO ACIDS MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2015-03-05 WO disclosed
EP-2311452-B9 Topical composition comprising n-acetyl glucosamine YU RUEY J (US) 2014-12-24 EP disclosed
US-RE44302-E1 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use YU RUEY J (US) 2013-06-18 US disclosed
US-RE44017-E1 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use YU RUEY J (US) 2013-02-19 US disclosed
US-RE42902-E1 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use TRISTRATA, INC. (US) 2011-11-08 US disclosed
EP-2311452-A1 Topical composition comprising n-acetyl glucosamine Yu, Ruey J. (US) 2011-04-20 EP disclosed
US-RE41339-E1 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use TRISTRATA, INC. (US) 2010-05-18 US disclosed
US-RE41278-E1 N-acetyl aldosamines and related N-acetyl compounds, and their topical use TRISTRATA, INC. 2010-04-27 US disclosed
EP-2080504-A2 Topical composition comprising n-acetylaldosamines or n-acetylamino acids Yu, Ruey J. (US) 2009-07-22 EP disclosed
EP-1570840-B1 Topical composition comprising n-acetylamino acids YU RUEY J (US) 2009-04-01 EP disclosed
EP-1639994-A2 Topical composition comprising N-acetylaldosamines or N-acetylamino acids Yu, Ruey J., Dr. (US) 2006-03-29 EP disclosed
EP-1570840-A2 TOPICAL COMPOSITION COMPRISING N-ACETYLALDOSAMINES OR N-ACETYLAMINO ACIDS Yu, Ruey J., Dr. (US) 2005-09-07 EP disclosed
EP-0959355-B1 Reagents for the detection and quantification of thryoxine in fluid samples ABBOTT LAB (US) 2003-05-14 EP disclosed
US-6524593-B1 Alleviate or improve various cosmetic conditions and dermatological disorders, skin, hair, nails TRISTRATA, INC. 2003-02-25 US disclosed
US-6159485-A COSMETICS; SKIN DISORDERS YUGENIC LIMITED PARTNERSHIP (US) 2000-12-12 US disclosed
EP-0649533-B1 REAGENTS AND METHODS FOR THE DETECTION AND QUANTIFICATION OF THYROXINE IN FLUID SAMPLES ABBOTT LAB (US) 2000-05-10 EP disclosed
EP-0959355-A1 Reagents for the detection and quantification of thryoxine in fluid samples ABBOTT LABORATORIES (US) 1999-11-24 EP disclosed
EP-0653066-B1 PHOTOACTIVATABLE CHEMILUMINESCENT MATRICES BEHRINGWERKE AG (DE) 1998-01-28 EP disclosed
US-5709994-A PHOTOSENSITIZER, SINGLET OXYGEN GENERATION SYNTEX (U.S.A.) INC. (US) 1998-01-20 US disclosed
US-5691456-A IMMUNOGENS CONTAINING BOVINE SERUM ALBUMIN AND FLUORESCEIN COMPOUND ABBOTT LABORATORIES (US) 1997-11-25 US disclosed
US-5688921-A IMMUNOGENS CONTAINING BOVINE SERUM ALBUMIN AND FLUORESCEIN COMPOUND ABBOTT LABORATORIES D-337/AP6D (US) 1997-11-18 US disclosed
US-5648272-A Reagents and methods for the detection and quantification of thyroxine in fluid samples ABBOTT LABORATORIES (US) 1997-07-15 US disclosed
US-5618732-A COMBINING IN A MEDIUM A CHEMILUMINESCENT CAPABLE OF EMITTING LIGHT UPON IRRIDATION AND A SOLID MATRIX HAVING A PHOTOSENSITIZER WHICH UPON ACTIVATION GENERATES A SINGLET OXYGEN, WHICH ACTIVATES LUMINESCENT, COMPARING DECAY TIME BEHRINGWERKE AG (DE) 1997-04-08 US disclosed
US-5593896-A COMPETITIVE IMMUNOASSAY ABBOTT LABORATORIES (US) 1997-01-14 US disclosed
EP-0649533-A4 REAGENTS AND METHODS FOR THE DETECTION AND QUANTIFICATION OF THYROXINE IN FLUID SAMPLES. ABBOTT LAB (US) 1996-08-21 EP disclosed
EP-0653066-A1 PHOTOACTIVATABLE CHEMILUMINESCENT MATRICES BEHRINGWERKE Aktiengesellschaft (DE) 1995-05-17 EP disclosed
EP-0649533-A1 REAGENTS AND METHODS FOR THE DETECTION AND QUANTIFICATION OF THYROXINE IN FLUID SAMPLES ABBOTT LABORATORIES (US) 1995-04-26 EP disclosed
US-5359093-A For sensitive immunoassays ABBOTT LABORATORIES (US) 1994-10-25 US disclosed
WO-1994003812-A1 PHOTOACTIVATABLE CHEMILUMINESCENT MATRICES SYNTEX (U.S.A.) INC. (US) 1994-02-17 WO disclosed
WO-1993020442-A1 REAGENTS AND METHODS FOR THE DETECTION AND QUANTIFICATION OF THYROXINE IN FLUID SAMPLES ABBOTT LABORATORIES (US) 1993-10-14 WO disclosed
US-5001072-A Compositions and methods for multiple simultaneous immunoradiometric assay (IRMA) of analytes using radioisotope chelate labels ICN BIOMEDICALS INC. (US) 1991-03-19 US disclosed
US-4801726-A HYDRAZIDE SILICAS NORTHEASTERN UNIVERSITY (US) 1989-01-31 US disclosed
US-4614823-A FOR DETERMINATION OF LIGANDS IN BIOLOGICAL FLUIDS ABBOTT LABORATORIES (US) 1986-09-30 US disclosed
US-4550163-A Ligand analog-irreversible enzyme inhibitor conjugates ABBOTT LABORATORIES (US) 1985-10-29 US disclosed
US-4510251-A Fluorescent polarization assay for ligands using aminomethylfluorescein derivatives as tracers ABBOTT LABORATORIES (US) 1985-04-09 US disclosed
US-4489165-A CONJUGATE OF LIGAND, SPACER, AND CHROMOGEN BECTON DICKINSON AND COMPANY (US) 1984-12-18 US disclosed
EP-0110186-A1 Aminomethylfluorescein derivatives ABBOTT LABORATORIES (US) 1984-06-13 EP disclosed
US-4430263-A TRYPSIN INHIBITOR CONJUGATE WITH HAPTEN OR THYROXINE ABBOTT LABORATORIES (US) 1984-02-07 US disclosed
US-4341865-A THYROXINE IRREVERSIBLE ENZYME INHIBITOR CONJUGATE, ENZYME, ENZYME SUBSTRATE ABBOTT LABORATORIES (US) 1982-07-27 US disclosed
US-4273866-A IMMUNOASSAY FOR QUANTITATIVE ANALYSIS OF ACETYLCHOLINESTERASE ABBOTT LABORATORIES (US) 1981-06-16 US disclosed
US-4273866-A IMMUNOASSAY FOR QUANTITATIVE ANALYSIS OF ACETYLCHOLINESTERASE ABBOTT LABORATORIES (US) 1981-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250059237-A1 METHODS OF FORMING RADIOPAQUE PEPTIDES AND MEDICAL HYDROGELS FORMED THEREFROM HDGF, IAPP, QRFPR THRB 862/4885THRA 797/4885MEN1 420/4885
US-20260115330-A1 RADIOPAQUE MULTI-ARM POLYMERS FOR MEDICAL APPLICATIONS KLK3, BRDT, BPHL THRB 955/4885THRA 358/4885MEN1 1567/4885
US-20260049178-A1 CROSSLINKING AGENTS AND MEDICAL HYDROGELS FORMED THEREFROM NPPA, MACF1, IGF1R THRB 651/4885THRA 39/4885MEN1 1139/4885
US-20260014282-A1 METHODS OF FORMING RADIOPAQUE PEPTIDES FOR USE IN MEDICAL HYDROGELS IAPP, NPPA, ARG1 THRB 434/4885THRA 330/4885MEN1 611/4885
US-20240216539-A1 VECTOR FOR DELIVERING ACTIVE AGENT TO NERVOUS SYSTEM, AND USE THEREOF TTR, HAVCR2, PMP22 THRB 487/4885THRA 135/4885MEN1 2516/4885
US-20260041799-A1 HYDROLYSIS-RESISTANT HYDROGELS AND METHODS OF TREATMENT USING SAME PAM, CRYAA, COL1A1 THRB 2135/4885THRA 562/4885MEN1 2882/4885
US-20250249130-A1 RADIOPAQUE POLYPEPTIDES FOR INJECTABLE COMPOSITIONS IAPP, IGFBP6, NPPA THRB 1550/4885THRA 2016/4885MEN1 242/4885
US-20250049964-A1 INJECTABLE SHEAR-THINNING AND SELF-ASSEMBLING HYDROGELS CD44, F12, MSN THRB 3406/4885THRA 3526/4885MEN1 2801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.